10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023

ElSayed, Nuha A., Aleppo, Grazia, Aroda, Vanita R., Bannuru, Raveendhara R., Brown, Florence M., Bruemmer, Dennis, Collins, Billy S., Das, Sandeep R. +14 more·2023·Diabetes Care

DOI 10.2337/dc23-s010

Cited by (453)

Items 201–300 of 453

Type 2 diabetes disease and management patterns across a large, diverse healthcare system: Issues and opportunities for guideline-directed therapies
Alexander J. Blood, Lee‐Shing Chang, Caitlin Colling, Gretchen M. Stern, Daniel Gabovitch, David Zelle, Emily W. Zacherle, Joshua Noone, Carey Robar, Samuel Aronson et al. · 2025 · American Heart Journal
Beyond overweight, visceral adiposity is associated with estimation of cardiovascular risk in patients living with type 1 diabetes: findings from the SFDT1 cohort
Laurence Salle, Jean‐Baptiste Julla, Guy Fagherazzi, Pierre Gourdy, Erika Bezerra Parente, Hélène P. Hanaire, Sopio Tatulashvili, Emmanuel Disse, Sylvia Franc, Samy Hadjadj et al. · 2025 · Cardiovascular Diabetology
Clinical Significance of Diabetes in Asymptomatic Individuals With Zero Coronary Artery Calcium Score
Yong‐Hoon Yoon, Tae Oh Kim, Gyung‐Min Park, Jong‐Young Lee, Jae‐Hyung Roh, Jae‐Hwan Lee, Kyusup Lee, Pil Hyung Lee, Jaewon Choe, Young‐Hak Kim et al. · 2025 · The American Journal of Cardiology
The association between stress hyperglycemia ratio and 1-year outcomes in patients with acute myocardial infarction: a retrospective large sample cohort study
Ning Yan, Peng Wu, Zhengjun Zhang, Mohan Wang, Juan Ma, Dapeng Chen, Shaobin Jia, Xueping Ma, Xiaocheng Li, Juan Ma · 2025 · Frontiers in Endocrinology
The Evolving Role of C-Reactive Protein in Heart Failure
Ishwarlal Jialal, Imo Ebong · 2023 · Journal of the American College of Cardiology
Type 2 diabetes specialist care in Italy in the AMD Annals initiative 2024: The path is traced
Giuseppina Tiziana Russo, Salvatore De Cosmo, Antonio Nicolucci, Valeria Manicardi, Alberto Rocca, Giuseppe Lucisano, Maria Cecilia Rossi, Paolo Di Bartolo, Graziano Di Cianni, Riccardo Candido · 2025 · Diabetes Research and Clinical Practice
Diabetes knowledge, attitudes and practices among Chinese primary care physicians: a cross-sectional study
Pi, Linhua, He, BinBin, Fei, Dongxue, Shi, Xiajie, Zhou, Zhiguang · 2024 · BMC Primary Care
Impact of Guideline-Directed Statin Intervention for Primary Prevention in Patients With Diabetes
Pallavi Muluk, Jianhui Zhu, Floyd W. Thoma, Eli Hay, Oscar C. Marroquin, Amber Makani, Aryan Aiyer, Khurram Nasir, Martha Gulati, Michael David Shapiro et al. · 2023 · Diabetes Care
Sex-specific differences in myocardial glucose metabolic rate in non-diabetic, pre-diabetic and type 2 diabetic subjects
2024
Evaluation of pharmacist-led transition of care program in patients with acute coronary syndrome
Graham, Jove, Voyce, Stephen J., Hayden, Jessica R. et al. · 2024 · Journal of the American Pharmacists Association
Enhanced Outcomes in Type 2 Diabetes Patients With Acute Kidney Disease Through Thiazolidinedione
Li‐Yang Chang, Hung‐Wei Liao, Jui‐Yi Chen, Vin‐Cent Wu · 2024 · The Journal of Clinical Endocrinology & Metabolism
Impact of Preeclampsia and Parity on Sex-based Discrepancies in Subclinical Carotid Atherosclerosis in Type 1 Diabetes
Verónica Perea, Irene Vinagre, Tonet Serés‐Noriega, Clara Viñals, Alex Mesa, Adriana Pané, Camila Milad, Enric Esmatjes, Ignacio Conget, Marga Giménez et al. · 2023 · The Journal of Clinical Endocrinology & Metabolism
The Possible Impact of COVID-19 on Glycated Hemoglobin and Systolic Blood Pressure in Type 2 Diabetes and Obesity
Tatiana Palotta Minari, Carolina Freitas Manzano, Louise Buonalumi Tácito Yugar, Luis Gustavo Sedenho‐Prado, Tatiane de Azevedo Rubio, Lúcia Helena Bonalume Tácito, Antônio Carlos Pires, José Fernando Vilela-Martin, Luciana Neves Cosenso‐Martin, Nelson Dinamarco Ludovico et al. · 2024 · Obesities
Prescription Fills Among Patients With Type 2 Diabetes After Hospitalization for Acute Coronary Syndrome
Michelle D. Kelsey, Cassie B. Ford, Megan M. Oakes, Samir S. Soneji, Hayden Barry Bosworth, Neha Jadeja Pagidipati · 2024 · JAMA Network Open
Predict and prevent microvascular complications of type 2 diabetes: a cross-sectional and longitudinal study in Chinese communities
Zhaoxiang Liu, Lianhao Zhou, Wenhui Zhao, Lixia Jin, Jinping Zhang, Yajing Zhang, Yufeng Li, Guixia Deng, HE Ji-quan, Xinghua Zhao et al. · 2025 · Frontiers in Endocrinology
Association between delayed statin initiation after high LDL-cholesterol detection and cardiovascular risk in general health screening examinees
Jinsun Lee, Min Woo Kang, Juhwan Oh, Minsang Kim, Jung Hun Koh, Eunjeong Kang, Jeong Min Cho, Semin Cho, Seong Geun Kim, Soojin Lee et al. · 2025 · European Heart Journal - Quality of Care and Clinical Outcomes
Patient perceptions of cardiovascular risk, lipid management and statins in type 1 diabetes
Lan, Nick S.R., Hong, Regina S.Y., Ryan, Christopher · 2023 · Primary Care Diabetes
Effects of an Electronic Medical Records-Linked Diabetes Self-Management System on Treatment Targets in Real Clinical Practice: Retrospective, Observational Cohort Study
So Jung Yang, Sun‐Young Lim, Yoon‐Hee Choi, Jin‐Hee Lee, Kun‐Ho Yoon · 2024 · Endocrinology and Metabolism
Risk of hyperkalaemia in patients with type 2 diabetes mellitus prescribed with SGLT2 versus DPP-4 inhibitors
Mei‐Zhen Wu, Tiew‐Hwa Katherine Teng, Christopher Tze‐Wei Tsang, Yap‐Hang Chan, Chi‐Ho Lee, Q W Ren, Jiayi Huang, Iokfai Cheang, Yi-Kei Tse, Xinli Li et al. · 2023 · European Heart Journal - Cardiovascular Pharmacotherapy
Presence of coronary artery disease in adults with newly detected diabetes mellitus
2025
A multidisciplinary, shared care clinic using personalized medicine and coordinated care in patients with concomitant type 2 diabetes and cardiovascular disease. Protocol and baseline characteristics
Julie R.N. Pontoppidan, Emil Eik Nielsen, Michael Hecht Olsen, Michael Kriegbaum Skjødt, Jesper Olund Christensen, Ilan Esra Raymond, Sara Hedlund Møller, Anne Merete Boas Soja, Peter Gæde · 2024 · Preventive Medicine Reports
Weight adjusted waist index is a superior obesity index for predicting arterial stiffness in type 2 diabetes mellitus
Shijun Gong, Jing Mao, Quan Zhou, Haifeng Zhou, Qin Liu, Ting Sun, Shenglian Gan · 2025 · Scientific Reports
Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: results from REDUCE-IT
P.M. Burger, Deepak L. Bhatt, Jannick A N Dorresteijn, Stefan Koudstaal, Arend Mosterd, Fabrice M A C Martens, Philippe Gabríel Steg, Frank L.J. Visseren, for the REDUCE-IT Investigators, Joanne Ladner et al. · 2024 · European Heart Journal - Cardiovascular Pharmacotherapy
Prevalence, patterns, and determinants of vascular complications of type 2 diabetes in a teaching hospital in Addis Ababa, Ethiopia: a retrospective study
Solela, Gashaw, Gessesse, Henok A., Zegeye, Hailu, Worku, Amare, Leulseged, Beza · 2024 · BMC Endocrine Disorders
Effect of Urinary Albumin Creatinine Ratio on Cardiovascular Morbidity and Mortality in Diabetes Patients with Atherosclerotic Disease
Fei Gao, Yang Zhou, Xiaoming Yan, Haozhang Huang, Guoxiao Liang, Yong-Yi Xie, Qijiong Zhu, Ziming Chen, Bo Wang, Huanqiang Li et al. · 2023 · Diabetes Metabolic Syndrome and Obesity
Mortality in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)
Mary Ann Banerji, John B. Buse, Naji Younes, Heidi J Krause-Steinrauf, Adline Ghazi, Melissa Lee, Jean Park, Rodica Pop‐Busui, Chantal Underkofler, Stephen P. Fortmann et al. · 2024 · Diabetes Care
Optimal Medical Therapy for Stable Ischemic Heart Disease in 2024
Timothy Abrahams, Stephen James Nicholls, Adam J. Nelson · 2024 · Medical Clinics of North America
Status of lipid control in Bangladeshi subjects with type 2 diabetes mellitus on lipid-lowering drugs: a multicenter, facility-based, cross-sectional study
Shahjada Selim, Muhammad Shah Alam, Samir Kumar Talukder, Md Lutful Kabir, Md Abu Jar Gaffar, Md Ahamedul Kabir, Nusrat Zarin, Shahin Ibn Rahman, Md Masud Un Nabi, Marufa Mustari et al. · 2023 · BMC Endocrine Disorders
Association of Glucagon-Like Peptide-1 Receptor Agonist with Incident Atrial Fibrillation
Suzan Khalil, William Hicks, Floyd W. Burke, Ishak A. Mansi · 2025 · American Journal of Cardiovascular Drugs
Comprehensive analysis of Syzygium cumini L. pomace extract as an α-amylase inhibitor: In vitro inhibition, kinetics, and computational studies
Venkatramanan Varadharajan, Ashwath Kumar Balu, Bruce Joshua Sinclair, Gopi Krishna Perinbarajan, Dharshini Jenifer. A, Harish Ganesan Sudha, Arulvel Ramaswamy, Baskar Venkidasamy, Muthu Thiruvengadam · 2025 · Bioorganic Chemistry
Treat-to-target versus high-intensity statin treatment in patients with or without diabetes mellitus: a pre-specified analysis from the LODESTAR trial
Seung‐Jun Lee, Woong Chol Kang, Jong‐Young Lee, Jin‐Bae Lee, Tae‐Hyun Yang, Junghan Yoon, Yong‐Joon Lee, Sung‐Jin Hong, Chul‐Min Ahn, Jung‐Sun Kim et al. · 2023 · EClinicalMedicine
Composite cardiovascular risk factor control in US adults with diabetes and relation to social determinants of health: The All of Us research program
Frances Golden, Johnathan Tran, Nathan D. Wong · 2025 · American Journal of Preventive Cardiology
Empagliflozin and Dapagliflozin Improve Endothelial Function in Mexican Patients with Type 2 Diabetes Mellitus: A Double-Blind Clinical Trial
Luis Ricardo Balleza-Alejandri, Fernando Grover Páez, Erick González Campos, Carlos G. Ramos Becerra, Ernesto Muñoz, Sara Pascoe González, Maria Guadalupe Ramos-Zavala, Africa Samantha Reynoso-Roa, Daniel Osmar Suárez-Rico, Alberto Beltrán-Ramírez et al. · 2024 · Journal of Cardiovascular Development and Disease
Investigating the Relationship Between Lipid-Lowering Agents and the Complications of Diabetic Retinopathy
Hejin Jeong, Jacqueline K. Shaia, Katherine E. Talcott, Rishi P. Singh · 2024 · Ophthalmic surgery, lasers & imaging retina
Chronic kidney disease progression in diabetic patients: Real world data in general practice
Michelangelo Rottura, Selene Francesca Anna Drago, Viviana Maria Gianguzzo, Antonino Molonia, Giovanni Pallio, Riccardo Scoglio, Sebastiano Marino, Angela Alibrandi, Egidio Imbalzano, Francesco Squadrito et al. · 2024 · Heliyon
Sensing Biomechanical Alterations in Red Blood Cells of Type 1 Diabetes Patients: Potential Markers for Microvascular Complications
Riccardo Di Santo, Benedetta Niccolini, Alessandro Rizzi et al. · 2024 · Biosensors
Lipid-lowering therapy and LDL-C control for primary prevention in persons with diabetes across 90 health systems in the United States
Emily Decicco, Eric David Peterson, Anand Gupta, Kristin Khalaf Gillard, Evelyn Sarnes, Ann Marie Návar · 2023 · American Journal of Preventive Cardiology
Persistence with once-weekly glucagon-like peptide 1 receptor agonist therapy decreases the risk of major adverse cardiovascular events: A retrospective analysis of patients with type 2 diabetes mellitus and atherosclerotic cardiovascular disease
Tyler J. Dunn, Yong Zhu, Noelle N. Gronroos, Lin Xie, Andrew Sargent, Cory L. Gamble, Liana K. Billings · 2025 · Diabetes Research and Clinical Practice
Associations Between Hematologic Parameters and All‐Cause Death in Individuals With Cardio‐Renal–Metabolic Multimorbidity: A National Cohort Study
Song Wen, Shuheng Zhou, Wei Wang, Xueting Qiu, Yingqing Feng · 2025 · Journal of the American Heart Association
The Association of Dyslipidemia and Atherogenic Indices With Glycemic Control in Diabetic Dyslipidemia Patients: A Real-World Landscape
Isaac J. Bage, Sadishkumar Kamalanathan, Sandhiya Selvarajan, Jayaprakash Sahoo, Jayanthi Mathaiyan, Dukhabandhu Naik · 2023 · Cureus
Glycaemic and weight effects of metabolic surgery or semaglutide in diabetes dosage for patients with type 2 diabetes
Erik Stenberg, Yang Cao, Johan Ottosson, Suzanne Hedberg, Erik B. Näslund · 2024 · Diabetes Obesity and Metabolism
Diabetes mellitus und kardiovaskuläre Prävention
Monika Kellerer, Hui Jing Qiu · 2023 · DMW - Deutsche Medizinische Wochenschrift
Indobufen Versus Aspirin Plus Clopidogrel in Patients After Coronary Stenting in Patients With Diabetes: A Post Hoc Analysis of the OPTION Trial
Shujing Wu, Huajie Xu, Lili Xu, Huanyi Zhang, Kang Cheng, Xiaoyan Wang, Manhua Chen, Guangping Li, Jiangnan Huang, Jun Lan et al. · 2025 · Journal of Diabetes
GLP-1 RAs vs. SGLT2is: Divergent pathways of cardiovascular inflammation control in obesity-associated diabetes
Ailish Hephzibah Samuel, Abhishek Hanumanpratap Singh Kshatri, Rithwik Nanda Babu, Harsh Shirishkumar Patel, Smera Hari Viswanathan, Mani Shankar Reddy Challa, N. L. Swathi · 2026 · Annales d Endocrinologie
High‐intensity statin therapy is associated with reduced coronary inflammation on CT in patients with type 2 diabetes mellitus
Bryan Wu, Koen Nieman, Ryan Sandoval · 2025 · Diabetes Obesity and Metabolism
Oxidative Stress in Type-2 Diabetes Mellitus
M. Asim, R. Awan, H. Ur Rashid, F. Hussain · 2024 · Springer eBooks
Development of an explainable machine learning model for 3-year cardiovascular risk prediction in new-onset type 2 diabetes using the TyG index and ultrasound features
Zhen-zhen Jiang, Yanfeng Jiang, Yue Wang, Ying Zhou, Rong-li Peng, MA Cai-ye, Xiatian Liu · 2025 · BMC Medical Informatics and Decision Making
Type 1 Diabetes and Cardiovascular Health
Maria Pesantez, Osagie A. Ebekozien, Francesco Vendrame · 2023 · Endocrinology and Metabolism Clinics of North America
Association between triglyceride-glucose index and all-cause mortality in critically ill patients with acute myocardial infarction: analysis of the MIMIC-IV database
Xin Yu Su, Yujing Zhou, Jie Chang · 2025 · Frontiers in Endocrinology
Optimal Definition and Risk Stratification in Prediabetes With Stable Coronary Heart Disease: A Prospective Cohort Study
Chenxi Song, Zheng Qiao, Jiaxi Cheng, Yuze Zhang, Weida Liu, Sheng Yuan, Jining He, Yanjun Song, Xiaohui Bian, Zhangyu Lin et al. · 2024 · Journal of the American Heart Association
The ESCAPER study—exploring protective mechanisms against cardiovascular disease in subjects at high risk: rationale, study protocol, and first results
Ola Ekström, Håkan Arheden, Anders G. Christensson, Gunnar Engström, Erik Hedström, Cecilia Kennbäck, Agnė Laučytė-Cibulskienė, Simon Lundgren, Valeriya Lyssenko, Magnus Löndahl et al. · 2025 · Scandinavian Cardiovascular Journal
Body Fat Depletion: the Yin Paradigm for Treating Type 2 Diabetes
Jingjing Zhu, John P.H. Wilding · 2023 · Current Atherosclerosis Reports
Improving Renal Protection in Chronic Kidney Disease Associated with Type 2 Diabetes: The Role of Finerenone
Pringgodigdo Nugroho · 2025 · Endocrine Metabolic & Immune Disorders - Drug Targets
Pharmacological mechanisms of Taohe Chengqi decoction in diabetic cardiovascular complications: A systematic review, network pharmacology and molecular docking
ZHANG Chun-peng, CAO Tian, YANG Xue · 2024 · Heliyon
Development and validation of a risk score nomogram model to predict the risk of 5-year all-cause mortality in diabetic patients with hypertension: A study based on NHANES data
Hongzhao You, Dingyue Zhang, Yilu Liu et al. · 2024 · International Journal of Cardiology Cardiovascular Risk and Prevention
Differential effects of milk, yogurt, and cheese on energy homeostasis and brown adipose tissue phenotype in high-fat diet-induced obese mice
2024
Maladie rénale chronique et diabète de type 2. Histologie, pathogénie et stades évolutifs
L. Monnier, S. Halimi, C Colette · 2023 · Médecine des Maladies Métaboliques
Optimizing lipid control in Taiwanese diabetic patients: A collaborative consensus by the Diabetes Association of the Republic of China (Taiwan) and the Taiwanese Association of Diabetes Educators
Feng‐Chih Shen, Chih‐Hsun Chu, Jung‐Fu Chen, Chin‐Sung Kuo, Chih‐Yao Hsu, Ching‐Han Lin, Yi‐Jing Sheen, Sheng‐Chiang Su, Kai‐Jen Tien, Chieh‐Hua Lu et al. · 2024 · Journal of Diabetes Investigation
Newer and novel antidiabetic drug classes across the cardiovascular–kidney–metabolic continuum
Konstantinos Stefanakis, Paschalis Karakasis, Dimitra Vasdeki, Djordje S. Popovic, Dimitrios Patoulias, Manfredi Rizzo, Christos Socrates Mantzoros · 2026 · Endocrine Reviews
Aspirin Dosing in Cardiovascular Disease and Diabetes: Insights From ADAPTABLE
David A. Aguilar, Barry R. Davis · 2023 · Diabetes Care
Risk factor control in relation to mortality and life expectancy among people with type 2 diabetes: results from 3 nationwide cohort studies
Zixin Qiu, Frank Qian, Yanbo Zhang, Jun Liu, Tingting Geng, Rui Li, Pang Yao, Oscar H. Franco, Eric B. Rimm, JoAnn Elisabeth Manson et al. · 2025 · Military Medical Research
Murottal Qur'an on Anxiety and Sleep Quality of Patients Undergoing Dialysis: Scoping Review
2024
AI-integrated smartphone platform enables POC dual-channel glucose monitoring with an indicator-free nanozyme gel kit
2026
Optimal LDL cholesterol levels in young and old patients with type 2 diabetes for secondary prevention of cardiovascular diseases are different
Chaiho Jeong, Bongseong Kim, Jinyoung Kim, Han-Sang Baek, Mee Kyoung Kim, Tae Seo Sohn, Ki‐Hyun Baek, Ki‐Ho Song, Hyun-Shik Son, Kyungdo Han et al. · 2023 · Endocrine Connections
Prognostic value of myocardial perfusion imaging in asymptomatic high-risk diabetic patients: 10-year follow-up of the prospective multicentre BARDOT trial
Thommen, Kathrin, Frey, Simon M, Kammerer, Daniel et al. · 2025 · European Heart Journal - Cardiovascular Imaging
Temporal trends in the starting of insulin therapy in type 2 diabetes in Italy: data from the AMD Annals initiative
Annalisa Giandalia, Antonio Nicolucci, M. Modugno, Giuseppe Lucisano, Maria Cecilia Rossi, Valeria Manicardi, Alberto Rocca, Graziano Di Cianni, Paolo Di Bartolo, Riccardo Candido et al. · 2024 · Journal of Endocrinological Investigation
Prevalence, impact and management of hypertension-mediated organ damage in type 2 diabetes patients
A.A. Romero Secin, Javier Díez‐Espino, Miguel Ángel Prieto-Díaz, Vicente Pallarés‐Carratalá, Alfonso Barquilla-García, Rafael Manuel Micó-Pérez, José Polo García, Sonsoles M. Velilla-Zancada, Vicente Martín, Antonio Segura‐Fragoso et al. · 2024 · Medicina de Familia SEMERGEN
Characteristics, glycemic control and outcomes of adults with type-2 diabetes mellitus attending specialized clinics in primary healthcare centers in Bahrain—A cross-sectional study
Mahmood Alawainati, Zahra A. Ayoob, Huda S. Naser · 2023 · Journal of Family Medicine and Primary Care
Hitting the Sweet Spot: A Review of SGLT2i in Cardiovascular Medicine
Zaid A. Zayyad, Neil Gupta, Aanya Roy, Swetha Kalagara, Atreya Mishra, Edward Salem, Suhas Rathna Seshadri, Deema Gichi, Bayan Hammad, Adriana Ene et al. · 2025 · Cardiology and Therapy
Risk Factors for Atherosclerotic Cardiovascular Disease
Carla Weidner, Lynne T. Braun · 2024 · Springer eBooks
Prevalence and risk factors of atherosclerotic cardiovascular disease in Egyptians with type 2 diabetes: findings from the PACT-MEA study and call for action
Samir Helmy Assaad Khalil, Atef Bassyouni, Dalia Nabil Toaima, Hanan Gawish, Hesham El Hefnawy, Magdy Helmy Zikry Megallaa, Manal Mohammed Abushady, Nabil Elkafrawy, Salwa Seddik Hosny, Tarek Mohamed Massoud · 2025 · BMJ Open
Lipid Control in Patients With Type 2 Diabetes Mellitus: A Continuous Quality Improvement Study
2025
Editorial commentary: Beyond coronary anatomy in acute myocardial infarction: Could stress hyperglycemia ratio be a new prognostic index and therapeutic target?
Matteo Armillotta, Luca Bergamaschi, Pasquale Paolisso · 2023 · Trends in Cardiovascular Medicine
Comparative mortality and its determinants in community-based people with type 1 diabetes: the Fremantle Diabetes Study Phase I
Ruwani Rajapaksa, Wendy Angela Davis, Timothy M. E. Davis · 2023 · BMJ Open Diabetes Research & Care
The relationship between remnant cholesterol and young-onset myocardial infarction in patients with type 2 diabetes: a retrospective study
Yajie Gao, Tianjiao Lei, Peizhu Dang, Yongxin Li · 2025 · Frontiers in Pharmacology
Macrovascular and microvascular complications of type 2 diabetes mellitus
М. Н. Мамедов, И. В. Друк, G. G. Arabidze, H. R. Akhundova · 2024 · Russian Journal of Preventive Medicine
Autologous and synthetic vascular grafts trigger different host responses in the anastomotic regions and in the perivascular adipose tissue during the early healing phase
Sabrina Rohringer, Sophie J. Specht, Anna-Maria Schmitt, Selin Topcu, Karl H. Schneider, Marjan Enayati, Christian Grasl, Katharina Ehrmann, Stefan Baudis, Herbert Kiss et al. · 2025 · Materials Today Bio
Type 2 Diabetes-Etiology, Epidemiology, Pathogenesis, Treatment
Carrie Burns, Nnenia Francis · 2023 · Springer eBooks
Minimization of drug interactions in polypharmacy treatments of diabetes mellitus type 2 with cardiovascular comorbidities by using the decision support tool PM-TOM
Adnan Kulenović, Azra Lagumdzija-Kulenovic · 2023 · Informatics in Medicine Unlocked
Association of statins with nonalcoholic fatty liver disease in patients with diabetes
Raj Shah, Alexander Kong, Silvio W. de Melo Jr, Moheb Boktor, Richard Henriquez, Amar B. Mandalia, Hrishikesh V. Samant, Carlos A. Álvarez, Ishak A. Mansi · 2024 · Journal of Investigative Medicine
Correlates of Myopathy in Diabetic Patients Taking Statins
Sara Tariq, Lakshmi Goriparthi, Dina Ismail, Gauvain Kankeu Tonpouwo, Milan Thapa, Khizer Khalid, Ayden Charlene Cooper, Gutteridge Jean-Charles · 2023 · Cureus
Achievement of Treatment Goals and Mortality in Individuals with Diabetes: The ELSA-Brasil Study
Bruna Cristine Chwal, Rodrigo Citton Padilha dos Reis, María Inês Schmidt, Sandhi Maria Barreto, Rosane Härter Griep, Bruce Bartholow Duncan · 2023 · Journal of Clinical Medicine
Provider adherence to American Diabetes Association cardiovascular risk–reduction guidelines: An integrative review
Bullock, Jamie Eve · 2024 · Journal of the American Association of Nurse Practitioners
Real-world Impact of 3 and 4.5 mg Doses of Dulaglutide on Weight and Hemoglobin A1c in Patients With Type 2 Diabetes Mellitus
Amy Duong, Samantha Heacock, Sarah Amering, Lillian Brennan, Jineane V. Venci, Nicole M. Acquisto · 2023 · Annals of Pharmacotherapy
The contemporary landscape of cardiovascular optimization in type 2 diabetes: overcoming barriers to evidence-based use of newer antihyperglycemic agents
Konstantinos Malas, Salman Kazmi, Yu Mi Kang, Darren K. McGuire · 2025 · Expert Opinion on Pharmacotherapy
Comparative effectiveness of GLP-1 RAs and other glucose-lowering therapies among Medicare Advantage beneficiaries with T2D and ASCVD
Xi Tan, Yuanjie Michael Liang, Lin Xie, Cynthia Gutierrez, Joanna G. Harton, Chalak Muhammad, Caroline Swift, Adam de Havenon · 2025 · Current Medical Research and Opinion
Screening of antihyperglycemic and cytotoxic properties of Ficus racemosa L. Fruit extract
Ananta Swargiary, Manita Daimari, Akalesh K. Verma · 2025 · In Silico Pharmacology
Evaluation of cardiovascular disease in diabetic patients using machine learning techniques
Silpa Nrusimhadri, Sangram Keshari Swain, V. V. R. Maheswara Rao, Shiva Shankar Reddy, Gadiraju Mahesh · 2024 · International Journal of Public Health Science (IJPHS)
Repurposing colchicine for reduction of residual inflammatory risk in type 1 diabetes: Design and rationale of the REC1TE trial
David S. Mathiesen, Josefine V. Hansen, Aske Høck, Casper K. Nielsen, Miriam G. Pedersen, Peter Lommer Kristensen, Henrik Ullits Andersen, Marie Louise Aarestrup, Julie Lyng Forman, Jonatan Ising Bagger et al. · 2025 · Diabetes Obesity and Metabolism
Health Impact of a Mobile-Delivered Diabetes Intervention to Control Blood Pressure in Older Adults
Koren S. Goodman, Elizabeth R. Locke · 2024 · AJPM Focus
Consumption of Ultra-Processed Foods and Metabolic Parameters in Type 2 Diabetes Mellitus: A Cross-Sectional Study
Júlia Bauer, Fernanda Oliveira Ayala, Aline Marcadenti, Rachel Helena Vieira Machado, Ângela Cristine Bersch-Ferreira, Maria Fernanda Souza Moreira, Mileni Vanti Beretta, Ana Maria Pandolfo Feóli, Fernanda Michielin Busnello · 2025 · International Journal of Environmental Research and Public Health
Comparing ischemic cardiovascular effectiveness and safety between individual SGLT-2 inhibitors and DPP-4 inhibitors in patients with type 2 diabetes: a nationwide population-based cohort study
Hayeon Kim, Jun‐Ho Seo, Jin Hyun Nam, Yejee Lim, Kyung Hee Choi, Kyungim Kim · 2024 · Frontiers in Pharmacology
Prognostic Impact of On-Treatment Cumulative Ambulatory Blood Pressures for Adverse Macro- and Microvascular Outcomes in Individuals With Type 2 Diabetes: The Rio de Janeiro Type 2 Diabetes Cohort
Claudia R.L. Cardoso, Nathalie Carvalho Leite, Gil Fernando Salles · 2023 · Hypertension
The Michigan Collaborative for Type 2 Diabetes (MCT2D): Development and implementation of a statewide collaborative quality initiative
Lauren D. Oshman, Neha Bhomia, Heidi L. Diez, Jonathan G. Gabison, Sherri Sheinfeld Gorin, Dina Hafez, Rina Hisamatsu, Michael Heung, Cornelius D. Jamison, KATHERINE L. KHOSROVANEH et al. · 2024 · BMC Health Services Research
Consistent glycaemic efficacy and safety of concomitant use of iGlarLixi and sodium-glucose co-transporter-2 inhibitor therapy for type 2 diabetes: A patient-level pooled analysis of three randomised clinical trials
Francesco Giorgino, Cristian Guja, Hasan Aydın, Felipe Lauand, Lydie Melas‐Melt, Julio Rosenstock · 2024 · Diabetes Research and Clinical Practice
Improving Hypertension Control in Vulnerable Populations Around the World
2023
Living with Type 2 Diabetes: Podcast of a Patient–Physician Discussion
Pamela R. Kushner, Anne Dalin · 2023 · Diabetes Therapy
Pain Intensity After Cardiac Surgery and its Association With Kinesiophobia: A Descriptive Study
Seda Nur Çatal, Yeşim Yaman Aktaş · 2024 · Journal of PeriAnesthesia Nursing
Estimated risk of cardiovascular events and long-term complications: The projected future of diabetes patients in Delhi from the DEDICOM-II survey
Swapnil Rawat, Ramasheesh Yadav, Siddhi Goyal, Jitender Nagpal · 2023 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
Break the “HOLD”: The Need to Strengthen the Management of Hypertension, Obesity, Lipids, and Diabetes (HOLD) and Improve Cardiovascular Health in People With Diabetes
Layla A. Abushamat, Vijay Nambi · 2023 · Journal of the American Heart Association